DaVita HealthCare Partners Inc  

(Public, NYSE:DVA)   Watch this stock  
Find more results for DVA
127.28
+0.67 (0.53%)
Real-time:   11:08AM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 125.92 - 128.38
52 week 79.19 - 131.33
Open 126.69
Vol / Avg. 136,142.00/877,083.00
Mkt cap 13.45B
P/E 30.62
Div/yield     -
EPS 4.16
Shares 105.70M
Beta 0.41
Inst. own 88%
Jul 29, 2013
Q2 2013 DaVita HealthCare Partners Inc Earnings Release Add to calendar
Jun 17, 2013
DaVita HealthCare Partners Inc Annual Shareholder Meeting - 11:30AM EDT - Add to calendar
May 7, 2013
Q1 2013 DaVita HealthCare Partners Inc Earnings Conference Call - Webcast
Apr 29, 2013
Q1 2013 DaVita HealthCare Partners Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 1.64% 7.84%
Operating margin 5.90% 15.84%
EBITD margin - 20.89%
Return on average assets 1.15% 5.15%
Return on average equity 1.80% 18.16%
Employees 53,400 -
Carbon Disclosure Rating - -

Address

2000 16th Street
DENVER, CO 80202
United States - Map
+1-303-4052100 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

DaVita HealthCare Partners Inc., formerly DaVita Inc., is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2011, the Company provided dialysis and administrative services through a network of 1,809 outpatient dialysis centers located in the United States throughout 43 states and the District of Columbia, serving a total of approximately 142,000 patients. It also provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services throughout the United States. On November 1, 2012, the Company announced the consummation of the merger of HealthCare Partners Holdings, LLC (HCP), with Seismic Acquisition LLC, with HCP as the surviving entity. In January 2013, the Company acquired nine dialysis centers from Fresenius Medical Care (FMC), provider of dialysis services and manufacturer of dialysis products.

Officers and directors

Kent J. Thiry Co-Chairman of the Board, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Robert J. Margolis M.D. Co-Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Javier J. Rodriguez President
Age: 42
Bio & Compensation  - Reuters
James K. Hilger Interim Chief Financial Officer, Chief Accounting Officer
Age: 51
Bio & Compensation  - Reuters
Dennis L. Kogod Chief Operating Officer
Age: 53
Bio & Compensation  - Reuters
Jeanine M. Jiganti Chief Compliance Officer
Age: 53
Bio & Compensation  - Reuters
LeAnne M. Zumwalt Group Vice President
Age: 54
Bio & Compensation  - Reuters
Laura A. Mildenberger Chief People Officer
Age: 54
Bio & Compensation  - Reuters
Allen R. Nissenson M.D. Chief Medical Officer
Age: 66
Bio & Compensation  - Reuters
David T. Shapiro Chief Special Counsel
Age: 43
Bio & Compensation  - Reuters